ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

HUMA Humacyte Inc

4.45
0.05 (1.14%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Humacyte Inc HUMA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.05 1.14% 4.45 23:00:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.50 4.36 4.57 4.41 4.40
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/3/202415:03EDGAR2Form SC 13D/A - General statement of acquisition of..
04/3/202405:53EDGAR2Form 8-K - Current report
29/2/202415:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202415:02EDGAR2Form 8-K - Current report
09/2/202407:06EDGAR2Form 8-K - Current report
12/12/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202307:06EDGAR2Form 8-K - Current report
09/11/202315:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202315:07EDGAR2Form 8-K - Current report
10/10/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202315:09EDGAR2Form SC 13D/A - General statement of acquisition of..
15/9/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202306:09EDGAR2Form 8-K - Current report
11/9/202319:03DJNStocks to Watch: Oracle, Acelyrin, Humacyte
21/8/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202315:28EDGAR2Form 144 - Report of proposed sale of securities
14/8/202307:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202306:05EDGAR2Form 8-K - Current report
31/7/202312:28DJNHumacyte Shares Rise 8% After Completing Enrollment in Phase..
26/7/202307:07EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock